Ghaemmaghami F, Ibanez J, Geelen G, Vincent M, Frutoso J, Gharib C
Laboratoire de Physiologie de l'Environnement, Faculté de Médecine Lyon Grange-Blanche, France.
J Cardiovasc Pharmacol. 1990 Jan;15(1):68-74. doi: 10.1097/00005344-199001000-00011.
Adaptations to the effects of clonidine (CL) and rilmenidine (R) were studied during a 12-week training program (swimming) in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. Systolic blood pressure (SBP) was regularly measured during this period. Body weight (BW) was determined at the beginning and at the 12th week. Plasma parameters, cardiac determinations, vasopressin (pAVP), and plasma renin activity (PRA) were measured only at the end of the experiment. Both SBP and ponderal benefit were reduced by CL, R, and training. Contrary to beta-adrenoceptor blocking agents, we found no inhibition of the beneficial effect on SBP of training in combination with CL or R. Plasma and hypothalamic vasopressin were reduced by both drugs but only CL increased plasma renin activity (PRA) although its mechanisms of action are still not clearly understood. Our results suggest that CL and R as well as swim training can be considered as an effective countermeasure in SHR. Moreover, the heterogeneity of action of CL and R on some of the parameters tested is in favor of different pharmacological properties for these drugs.
在一项为期12周的训练计划(游泳)中,对自发性高血压大鼠(SHR)和Wistar-Kyoto(WKY)大鼠适应可乐定(CL)和利美尼定(R)作用的情况进行了研究。在此期间定期测量收缩压(SBP)。在实验开始时和第12周测定体重(BW)。仅在实验结束时测量血浆参数、心脏指标、血管加压素(pAVP)和血浆肾素活性(PRA)。CL、R和训练均降低了SBP和体重获益。与β-肾上腺素能受体阻断剂相反,我们发现联合使用CL或R时,训练对SBP的有益作用未受到抑制。两种药物均降低了血浆和下丘脑血管加压素,但只有CL增加了血浆肾素活性(PRA),尽管其作用机制仍不清楚。我们的结果表明,CL和R以及游泳训练可被视为SHR的有效对策。此外,CL和R对某些测试参数作用的异质性表明这两种药物具有不同的药理特性。